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The PROM1 Mutation p.R373C Causes an Autosomal
Dominant Bull’s Eye Maculopathy Associated with Rod,
Rod–Cone, and Macular Dystrophy
Michel Michaelides,*,1,2,3 Marie-Claire Gaillard,3,4 Pascal Escher,5 Leila Tiab,5
Matthew Bedell,6 Franc¸ois-Xavier Borruat,4 Daniel Barthelmes,7 Ruben Carmona,6
Kang Zhang,6 Edward White,2 Michelle McClements,1 Anthony G. Robson,1,2
Graham E. Holder,1,2 Keith Bradshaw,8 David M. Hunt,1 Andrew R. Webster,1,2
Anthony T. Moore,1,2 Daniel F. Schorderet,5,9 and Francis L. Munier*,4,5
PURPOSE. To characterize in detail the phenotype of five unre-
lated families with autosomal dominant bull’s eye maculopathy
(BEM) due to the R373C mutation in the PROM1 gene.
METHODS. Forty-one individuals of five families of Caribbean
(family A), British (families B, D, E), and Italian (family C)
origin, segregating the R373C mutation in PROM1, were ascer-
tained. Electrophysiological assessment, fundus autofluores-
cence (FAF) imaging, fundus fluorescein angiography (FFA),
and optical coherence tomography (OCT) were performed in
available subjects. Mutation screening of PROM1 was per-
formed.
RESULTS. The R373C mutant was present heterozygously in all
affected patients. The age at onset was variable and ranged
between 9 and 58 years, with most of the individuals present-
ing with reading difficulties. Subjects commonly had a mild to
moderate reduction in visual acuity except for members of
family C who experienced markedly reduced central vision.
The retinal phenotype was characterized by macular dystro-
phy, with retinal pigment epithelial mottling in younger subjects,
progressing to typical BEM over time, with the development of
macular atrophy in older patients. In addition, all members of
family C had typical features of RP. The electrophysiological
findings were variable both within and between families.
CONCLUSIONS. Mutations in PROM1 have been described to
cause a severe form of autosomal recessive RP in two families
of Indian and Pakistani descent. The results of this study have
demonstrated that a distinct redundant PROM1 mutation
(R373C) can also produce an autosomal dominant, fully pene-
trant retinopathy, characterized by BEM with little inter- and
intrafamilial variability, and retinal dystrophy with variable rod
or rod–cone dysfunction and marked intra- and interfamilial
variability, ranging from isolated maculopathy without gener-
alized photoreceptor dysfunction to maculopathy associated
with very severe rod–cone dysfunction. (Invest Ophthalmol
Vis Sci. 2010;51:4771–4780) DOI:10.1167/iovs.09-4561
Bull’s eye maculopathy (BEM) is a distinctive macular phe-notype characterized by annular retinal pigment epithe-
lium (RPE) atrophy with central sparing of the fovea. BEM was
initially described in association with chloroquine retinopathy
in 1966 by Kearns and Hollenhorst.1 BEM has now also been
associated with a heterogeneous group of inherited retinal
disorders with both autosomal recessive and dominant inheri-
tance patterns.2–5 This heterogeneity is illustrated by the elec-
trophysiological findings in a large panel of patients with BEM.
These findings were consistent with isolated macular dystro-
phy in 60% of cases, cone–rod or rod–cone dystrophy in 36%
of cases, and isolated cone dystrophy in 4%.6 BEM has been
reported in patients with various forms of retinitis pigmentosa
(RP): (1) in syndromic RP such as Bardet-Biedl syndrome,7 (2)
in nonsyndromic RP (e.g., RPGR-related RP),8 and (3) in RP
with Stargardt-like maculopathy.9
A previous report has described the presence of disease-
causing ABCA4 sequence variants in 35% of patients with
BEM.10 The genetic heterogeneity of BEM was recently ex-
tended to the mutation R373C in PROM1.11 This was achieved
by positional cloning after three large autosomal dominant pedi-
grees affected with bull’s eye macular dystrophy (MCDR2),12
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Stargardt-like disease (STGD4),13 and RP (Gaillard MC, et al. IOVS
2007;48:ARVO E-Abstract 3737) were all mapped to the short arm
of chromosome 4.
In this study the clinical spectrum in carriers of the PROM1
p.R373C mutation is further explored in detail by revisiting the
phenotypes of the original STGD4, MCDR2, and RP families
(families A, B, and C, respectively) and by examining two
newly ascertained families (D and E).
METHODS
Patients and Clinical Assessment
The study adhered to the tenets of the Declaration of Helsinki (1983
Revision) and was approved by the local ethics committees. Informed
consent was obtained from all subjects.
All available members of the five families had a complete clinical
examination, including best corrected Snellen visual acuity (BCVA). In
willing subjects, the assessment included Goldmann perimetry (Haag-
Streit AG, Ko¨niz, Switzerland) or standard automated perimetry (Hum-
phrey Perimeter, Carl Zeiss Meditec, Dublin, CA); electrophysiological
testing, including a full-field electroretinogram (ERG) and pattern ERG
(PERG) incorporating the protocols recommended by the International
Society for Clinical Electrophysiology of Vision (ISCEV)14,15; fundus
fluorescein angiography (FFA); and fundus autofluorescence (FAF)
imaging with a confocal scanning laser ophthalmoscope (cSLO; Hei-
delberg Retina Angiogram, HRA 2; Heidelberg Engineering, Heidel-
berg, Germany). Color vision testing was performed with Hardy-Rand-
Rittler (HRR) plates (American Optical Company, New York, NY).
Macular optical coherence tomography (OCT; Stratus OCT 3; Carl
Zeiss Meditec Inc., Dublin, CA) was also performed in a significant
FIGURE 1. Pedigrees of families A to
E. (✱) Subjects screened for the
R373C substitution. All affected pa-
tients were found to harbor the
R373C PROM1 mutation. No unaf-
fected patients were found to have
the R373C PROM1 mutation.
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proportion of patients. For analysis of retinal lamination abnormalities,
raw scan data were exported from the OCT device for further analysis,
and the light reflection profiles (LRPs) were calculated (IGOR Pro
6.03a; Wavemetrics Inc. Lake Oswego, OR).16–18 A 28-year-old normal
subject was used as a control for the OCT data analysis.
Molecular Genetic Analysis
Genomic DNA was extracted from the peripheral blood of the family
members by using a standard procedure. The p.R373C mutation had
been identified in all affected subjects in family A (STGD4) and family
B (MCDR2) after screening of the entire coding sequence and intron–
exon junctions of the prominin-1 (PROM1) gene in the probands.11
Families D and E were selected for directed screening for the R373C
PROM1 variant on the basis of clinical phenotype. In family C, a
whole-genome linkage analysis was performed that identified a disease
interval containing PROM1. The disease interval in family C was de-
fined by markers D4S403 (LOD score 3.31 for  0) and D4S419 (LOD
score 3.51 for  0). There were no other known or putative RP genes
in the interval. Mutation screening of the entire coding sequence and
intron–exon junctions of PROM1 was subsequently undertaken in the
index case, as previously described.11 In brief, amplification in a
thermal cycler (GeneAmp 9700; Applied Biosystems [ABI], Foster City,
CA), was performed in a total volume of 20 L. Each polymerase chain
reaction (PCR) contained 100 ng genomic DNA, 1 M of each primer,
and 10 L master mix 2 (Qiagen, Valencia, CA), with or without
betaine. PCR-amplified products were screened for mutations by using
denaturing high-performance liquid chromatography (DHPLC; WAVE
system; Transgenomics, Crewe, UK). PCR fragments displaying DHPLC
abnormal retention times were directly sequenced on both strands by
using dye termination chemistry (BigDye Terminator ver. 3.1; ABI), in
a final reaction volume of 10 L, and electrophoresed on a genetic
analyzer (Prism 3100; ABI). Sequences were aligned by computer
(Chromas 2.23 software; Technelysium, Tewantin, QLD, Australia),
with the reference genomic sequence provided by the Retina Interna-
tional Mutation Database (www.retina-international.org/ provided in
the public domain by a consortium of societies for eye diseases).
PROM1 was the only gene screened during this study.
RESULTS
Molecular Genetic Analysis
Screening of PROM1 revealed a C-to-T transition at position
1117 (c.1117CT) of the coding sequence (NM_006017.1),
which encodes a p.R373C substitution. This mutation segre-
gated heterozygously in all affected individuals from the five
families and was absent in the unaffected family members. In
family C, of the 20 individuals molecularly screened, 8 affected
subjects had the mutation, and 3 spouses and 9 first- or second-
degree unaffected relatives did not harbor the mutation. In
another study, the R373C variant was not identified in 400
normal control subjects (800 alleles; unrelated healthy individ-
uals of various ethnic backgrounds),11 and in the present study
a further 100 control subjects (200 alleles; white western
European origin) were screened and found not to harbor this
mutation. The following four sequence variants were also iden-
tified during the screening of PROM1 in family C: c.IVS2–6
CT, c.IVS1347 TC, c.IVS225 GC, and c.IVS234
AG. These are not believed to be disease-associated.
Clinical Features
To date, the patients reported herein have exhibited only an
ocular phenotype.
Family A (STGD4). The clinical findings in 14 affected
subjects from this four-generation Caribbean family (Fig. 1A)
are summarized in Table 1.TA
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The commonest presenting symptom was decreased visual
acuity, reported by nine patients at a mean age of 19 years
(range, 10–29 years). Visual acuity ranged from 6/6 to counting
fingers. Sixteen subjects had evidence of macular degenera-
tion, including macular RPE alterations (five patients), BEM
associated with various degrees of RPE atrophy (seven pa-
tients), and retinal flecks (two patients). FFA was performed in
five patients, revealing a dark choroid in one case and hyper-
fluorescent macular lesions in four other subjects. Full-field
ERGs revealed evidence of generalized rod photoreceptor dys-
function in III:14.
Family B (MCDR2). The clinical findings in seven affected
subjects from this five-generation nonconsanguineous British
family with autosomal dominant BEM (Fig. 1B) are summarized
in Table 1.
Most patients became symptomatic in the first to third
decade, with reduced central vision being the commonest
complaint. The majority of patients had normal or mildly re-
duced visual acuity. The most severely affected subjects were
BIII:2 (69 years) and BV:1 (23 years), both with visual acuity of
6/36 in at least one eye. The early macular abnormalities
included an increased foveal reflex and a red-speckled macular
appearance, progressing to a more classic BEM. FFA was per-
formed in two patients (BV:1 and BIV:2) and revealed localized
masking of choroidal fluorescence in the perifoveal area. A
dark choroid was not seen in either patient.
Full-field ERGs were normal in five patients; the two oldest
subjects exhibited mild generalized retinal dysfunction, with
mildly reduced rod photoreceptor function and borderline cone
responses in BIII:2 and isolated mildly reduced rod photoreceptor
responses in BIII:6. Three patients (BIII:6, BIV:2, and BV:1) had
repeat electrophysiological assessments 7 years after initial test-
ing. The amplitude of the PERG had reduced further in the
proband, BV:1. Full-field ERGs remained normal in BV:1 and
BIV:2, but there had been a progressive reduction in rod-mediated
responses in III:6, with cone responses remaining within normal
limits. The electrophysiological data were consistent with isolated
macular dysfunction in younger patients and suggested a very
slow deterioration of generalized rod photoreceptor function,
with sparing of cone responses, even in later life.
OCT was performed in five patients (BIII:6, BIV:2, BV:1, BV:3,
and BV:4) and revealed a reduction in total central retinal thick-
ness (Fig. 2). Shortening of photoreceptor outer segments, reduc-
tion of the outer nuclear layer, and a reduction in the reflec-
tivity of the photoreceptor cell layer were present in all scans,
but were more pronounced centrally (Fig. 2). The inner retinal
layers were less affected than the outer retinal layers, with
significant thinning of the inner plexiform and inner nuclear
layer, whereas the thickness of the ganglion cell layer was only
mildly reduced. Patients BV:3 and BV:4 showed outer retinal
LRPs very similar to those in control subjects, whereas the
inner retinal LRPs seem to be more altered. This observation
was made in these two individuals only.
Family C. The clinical findings in six affected subjects from
this four-generation nonconsanguineous Italian family with au-
tosomal dominant retinitis pigmentosa (adRP) (Fig. 1C) are
summarized in Table 1.
The age at onset was variable, ranging from 14 to 58 years.
Reduced central vision was the most common presenting
symptom, with night blindness being increasingly noticed over
time. BCVA ranged from 6/4.8 to hand motion. Fundus exam-
ination revealed BEM in all patients at a mean age of 34 years
(range, 7–54), which progressed over time to macular atrophy
(Fig. 3). A variable combination of the triad of typical retinal
features associated with RP was observed (Table 1, Fig. 3). FFA
was performed in all six patients and failed to reveal any
evidence of a dark choroid.
Full-field ERG recordings were consistent with a rod–cone
dystrophy in four patients, and rod- and cone-driven responses
were undetectable in the remaining two patients.
OCT imaging showed a significant overall decrease in
retinal thickness and marked changes in the outer retina,
similar to those in family B (Fig. 2). Analysis of retinal
lamination and calculation of LRP was performed in the two
youngest patients (CIV:1 and CIV:5). In individual CIV:1,
with nonconfluent macular atrophy, central and peripheral
macular (2 mm eccentricity) retinal thicknesses were re-
duced to 106  8 and 254  12 m, respectively (Fig. 2).
Loss of retinal thickness was mainly caused by a loss of
photoreceptor outer segments and thinning of the outer
nuclear layer (Fig. 2), whereas the structure of the inner
retina, especially the nerve fiber layer, showed fewer signs
of atrophy. In CIV:5, with marked macular atrophy, there
was evidence of more pronounced changes: central retinal
thickness was reduced to 76  6 m and peripheral macular
thickness to 170  14 m. This thinning was again mainly
due to loss of outer retinal structures, although in this
subject there was also evidence of significant loss of inner
retinal layers (Fig. 2), including the nerve fiber layer.
Family D. The clinical findings in two affected subjects
from this three-generation nonconsanguineous British family
(Fig. 1D) with autosomal dominant BEM are summarized in
Table 1.
The proband (DIII:1) noted central scotomata in the third
decade, and her mother (DII:2) was aware of reading difficul-
ties in the fourth decade. The proband was mildly affected
with visual acuity of 6/18 in the right eye (amblyopia) and 6/12
in the left, with her mother being severely affected with 6/60
vision in both eyes and describing a very slow deterioration
over a period of two decades. The proband had bilateral BEM
and optic nerve head drusen, whereas the mother had bilateral
macular atrophy and areas of hyperpigmentation (Fig. 4). The
proband underwent FFA, which revealed window defects at
the macula consistent with BEM (Fig. 4). There was no evi-
dence of a dark choroid.
Full-field ERGs were normal in the proband, with mildly
reduced rod photoreceptor function and borderline cone
responses in her mother, suggesting gradual deterioration in
generalized retinal function over time.
OCT imaging of patient DII:2 showed a generalized atrophy
of the neuroretinal tissue and the underlying RPE, with more
pronounced changes in the central macula (Fig. 2). There
seemed to be less evidence of retinal degeneration on OCT
imaging of the proband (DIII.1). However, detailed analysis
Š
FIGURE 2. OCT cross sections and calculated LRPs from the foveolar region (central) and the peripheral macular tissue (2 mm eccentricity) are
shown below the OCT cross sections for members of families B, C, D, and E. 1, retinal pigment epithelium; 2, ellipsoid of the photoreceptors; 3,
external limiting membrane; 4, outer plexiform layer; 5, inner plexiform layer; and 6, nerve fiber layer. Whereas in normal control subjects (black
line) the reflectivity peaks for the ellipsoid region of the photoreceptors (2) and the external limiting membrane (3) could easily be detected, this
signal was attenuated in all patients. Furthermore, in all individuals, both the foveal region and peripheral macular tissue were affected, with the
outer retina (outer nuclear layer, ellipsoid) showing more pronounced signs of degeneration than the inner retinal tissue. In the peripheral macular
tissue (2 mm from the center of the fovea) the damage was less pronounced than at the fovea with a preservation of lamination and well-preserved
signals from the inner retina. There was some variation regarding the more peripheral changes among the different individuals, but still, the pattern
of changes was very similar.
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revealed a significant loss of reflectivity in the central macula
area with respect to outer retinal structures. This loss was most
evident when looking at the thinned retina and at the loss of
the signal of the photoreceptor ellipsoid region, associated
with photoreceptor loss (peak 2, Fig. 2). The more peripheral
macular tissue appeared to be less affected, with the retinal
layering being relatively well preserved, although a reduction
in the outer nuclear layer thickness and loss of signal in the
ellipsoid region were noted (Fig. 2). The inner retina was far
less affected than the outer retinal tissue, in keeping with all
the other tested families.
Family E. The clinical findings in two affected subjects
from this three-generation nonconsanguineous British family
(Fig. 1E) with autosomal dominant BEM are summarized in
Table 1.
The proband reported having photophobia since child-
hood, and her sister became aware of reading difficulties and
reduced color vision in the fifth decade. The proband was
mildly affected with visual acuity of 6/6 in both eyes, but her
sister was more severely affected, with 6/12 in her right eye
and 6/6 in her left. Both sisters had bilateral BEM on ophthal-
moscopy, with the proband’s sister also having optic nerve
head drusen.
Full-field ERGs were normal in the sister (EIII:3). Full-field
ERGs were normal in the proband (EIII:1), when tested at
age 35 years, but on repeat testing at age 42 years there was
evidence of mildly reduced rod and cone photoreceptor
function, suggesting gradual mild generalized retinal dys-
function over time, in keeping with the other two British
families (B and D).
OCT was performed in patient EIII:1 and revealed find-
ings very similar to those obtained in subject DIII:1 (Fig. 2).
FIGURE 3. (A) Fundus and fluorescein angiography showing asymmet-
rical macular changes in this 60-year-old patient (CII:1) with bull’s eye
maculopathy in the right eye and geographic atrophy in the left eye.
(B) Fundus photograph showing bone spicule pigmentation through-
out the peripheral retina and retinal vessel attenuation in patient CIII:6
(58 years old). (C) AF imaging revealing two distinct phenotypes: (left)
a ring of high-density AF, with normal background AF of the retina
inside the vascular arcade (patient CIII:1; 58 years old) and (right) a
hypo- and hyperfluorescent pattern at the macula and up to the arcades
(patient CIII:6; 58 years old).
FIGURE 4. (A) Patient DIII:1 (32 years old): fundus photographs
showing bilateral bull’s-eye maculopathy and optic nerve head drusen.
(B) Patient DIII:1: fundus fluorescein angiography showing bilateral
perifoveal window defects corresponding to the retinal pigment epi-
thelial changes seen ophthalmoscopically. (C) Patient DIII:1: fundus AF
imaging revealing bilateral rings of increased perifoveal AF surrounding
mildly reduced foveal AF. (D) Patient DII:2 (65 years old): fundus
photographs showing bilateral macular atrophy and pigmentation. (E)
Patient DII:2: fundus AF imaging showing bilateral markedly reduced
macular AF corresponding to atrophy seen clinically, surrounded by
high-intensity AF rings.
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Reduced foveolar retinal thickness was observed, with loss
of the highly reflective signal originating from the outer
retina (Fig. 2), consistent with outer retinal disease. The
more peripheral macular region appeared to be better pre-
served than was the central macula, although there was also
evidence of a reduction of peripheral macular thickness,
mainly due to changes in the outer retina (reduced outer
nuclear layer thickness and outer segment shortening), in
keeping with the changes observed in subject DIII:1 (Fig. 2).
However, in contrast to patient DIII:1, patient EIII:1 also had
more pronounced inner retinal disease, with a notable re-
duction of the nerve fiber layer (Fig. 2).
DISCUSSION
In this study, we investigated in detail the PROM1 p.R373C-
related phenotype in five unrelated families originating from
the Caribbean, United Kingdom, and Italy. The mode of inher-
itance was found to be autosomal dominant with complete
penetrance. Variable expressivity was observed both between
and within families, with marked interocular asymmetry in
members of family C (RP phenotype). The patients, predomi-
nantly females (sex ratio, 0.41), first reported reading difficul-
ties between the first and third decades of life. The rate of
progression in most of the subjects was slow, with good visual
acuity being usually maintained until the sixth decade. How-
ever, in the family with RP (family C), a rapid and severe loss
of central vision and the development of night blindness and
marked visual field constriction were typically seen.
Affected individuals were most consistently found to have
BEM. The spectrum of macular phenotypes varied from mild
RPE changes to geographic atrophy, as the incipient and end-
stage manifestations of the disease respectively. In family C, the
characteristic macular phenotype was associated with features
of typical RP: bone spicule pigmentary deposits, vascular nar-
rowing, and pallor of the optic nerve head. In this family,
full-field ERGs confirmed the rod–cone nature of the dystro-
phy. In the other four families, the ERG was either normal (n
8) or displayed evidence of mild rod photoreceptor dysfunc-
tion, especially in the older patients (n  6), whereas cone
responses were normal (n  3), borderline (n  2), or mildly
reduced (n  1). These electrophysiological findings suggest
that rod photoreceptors may be more susceptible to the dele-
terious effects of the PROM1 p.R373C mutation than are pe-
ripheral cone cells. Interestingly, the patients with isolated
generalized rod dysfunction did not have any ophthalmoscopic
features of RP. Electrophysiological findings were variable both
between and within families, ranging from isolated macular
dysfunction to a generalized reduction in rod and cone re-
sponses. Environmental or other genetic modifying factors,
including sequence variation in PRPH2 and ROM1, may deter-
mine the extent of retinal dysfunction and phenotypic hetero-
geneity observed in this study.
There was both an inter- and intrafamilial variability with
respect to the OCT findings. Retinal degeneration was mildest
in family B (MCDR2), compared with the other three families,
with all members of family B having evidence of outer retinal
damage that was more pronounced in the central macula. The
inner retinal layers seemed to be less affected in this family,
showing a greater change in the central macula than in the
peripheral macular tissue. In the members of family C, degen-
erative changes were again present in the outer retina, albeit to
a greater degree than in family B. Although the extent of
degeneration, with additional significant involvement of inner
retinal tissue, was much greater than in family B, the pattern
was very similar. Findings in family D were in keeping with
those recorded in family C. Overall, the pattern of degenera-
tion was similar in families B, C, and D, with more pronounced
atrophy in the central macula and a greater involvement of the
outer retina. In contrast, in family E, there was evidence that
inner retinal atrophy (including the nerve fiber layer) was more
pronounced than outer retinal degeneration; however, only
one family member was available for OCT imaging. Although,
it is of note that electrophysiological testing did not reveal
evidence of inner retinal dysfunction in family E.
AF imaging identified two macular phenotypes with respect
to the presence (11/15) or absence (4/15) of a macular ring of
increased AF. The high-density ring of AF is due to an accumu-
lation of lipofuscin, which probably reflects the inability of the
RPE to process photoreceptor outer segments debris or alter-
natively may represent increased outer segment turnover. It
has been demonstrated histologically that the number of pho-
toreceptor cells is reduced in the presence of increased quan-
tities of lipofuscin in the RPE, leading to the proposal that
autofluorescent material may accumulate before cell death.
The ring of increased AF has been proposed to represent the
border between functional and dysfunctional retina and is well
documented in RP patients with preserved central vision and
preserved macular AF.19,20
Remarkably, the patients reported to date exhibited only an
ocular phenotype, despite the ubiquitous prominin-1 expres-
sion in plasma membrane protrusions (Table 2). A possible
explanation of this restricted phenotype is an absence of pro-
minin-2 expression in the eye.21,22 By functional redundancy,
this closely related protein may compensate for the absence of
prominin-1 in other tissues.22 In photoreceptors, prominin-1 is
concentrated in the plasma evaginations at the base of the
outer segment.22,23 The essential structural role of prominin-1
in outer segment morphogenesis and photoreceptor disc gen-
esis has been demonstrated in mice with a targeted disruption
of prominin-1 (prom1/).22 In this animal model, both cone
and rod outer segments are highly disorganized as early as
P12.22
TABLE 2. Prominin 1 Mutations Reported to Date
Nucleotide Change Amino Acid Change Inheritance Disease OMIM Reference
c.1117CT p.R373C Dominant STGD4 603786 Family A11,13
MCDR2 608051 Family B11,12
RP Family C (Gaillard MC, et al. IOVS
2007;48:ARVO E-Abstract 3737)
c.1726CT p.Q576X Recessive RP41 612095 24
c.1841delG p.G614fsX626 Recessive RP41 612095 23
c.1349insT p.Y452fsX12 Recessive CORD 25
The mutation nomenclature uses the first nucleotide of the ATG codon in the RefSeq cDNA NM_006017.1 as1. (MCDR2, macular dystrophy
retinal 2; i.e., autosomal dominant bull’s eye macular dystrophy; STGD4, Stargardt-like disease 4, i.e., autosomal dominant bull’s eye macular
dystrophy; RP41, retinitis pigmentosa 41; i.e., severe retinitis pigmentosa with macular degeneration; CORD, cone-rod dystrophy.)
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The three previously reported prominin-1 nonsense mutations
are recessively inherited, whereas the p.R373Cmissensemutation
acts in a dominant manner (Table 2). It is likely that the
p.G614fsX626, p.Q576X, and p.Y452fsX12 mutations would be
subject to nonsense-mediated mRNA decay and that the reces-
sively inherited retinal degenerations are due to the complete
absence of prominin-1.23–25 The p.R373C missense mutation
introduces an additional cysteine (Cys) residue in the predicted
first extracellular loop of prominin-1. It is of note that promi-
nin-1 contains multiple evolutionarily conserved Cys residues
that are also conserved in prominin-2.21 It is tempting to
speculate that the introduction of an additional Cys residue
disrupts a network of disulfide bridges and, in turn, impairs
homophilic protein interactions, causing a dominant pheno-
type. In Drosophila compound eyes, prominin-1 deficiency
converts the rhabdoms from an open to a closed configuration,
indicating evolutionarily conserved structural roles of promi-
nin-1 in photoreceptor formation and maintenance.26 A com-
parable phenotype is observed in Drosophila compound eyes
deficient in the agrin-perlecan related proteoglycan Eys (Eyes
shut)/spam (spacemaker).26,27 Recently, patients affected by
autosomal recessive RP carrying mutations in EYS have been
described.28 Whether differential expression levels of EYS
modify prominin-1-associated retinal dystrophies remains to be
determined.
In conclusion, we have identified a range of disease pheno-
types in families with the p.R373C mutation in PROM1, that
include isolated macular dysfunction, pure rod, and rod–cone
dystrophy. The phenotypic hallmark to date of the p.R373C
mutation is BEM. This consistent finding suggests that se-
quence variation in PROM1 should be considered in patients
presenting with BEM, particularly when accompanied by a
dominant family history.
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